New mechanisms of CCR5-Δ32 carriers' advantage - Impact on progenitor cells and renal function

Background: CCR5 is a chemokine receptor expressed by various populations including leukocytes, smooth muscle cells and endothelium. Delta 32 polymorphism of CCR5 gene has been connected with, inter alia, cardiovascular disease development. The aim of our study was to evaluate impact of CCR5 variant on CD34 + and CD34 + VEGFR2 + cells - populations involved in cardiovascular system homeostasis and regeneration. Methods and results: We have examined 170 Polish subjects from Pomeranian region. The analysis concerned CCR5 polymorphism and flow cytometry evaluation of whole blood cells. Our results indicate that individuals with at least one CCR5-Delta 32 allele are characterized by greater number of CD34 + CXCR4 + , CD34 + VEGFR2+ and CD34 + VEGFR2 + c-Kit + cells than their wild type counterparts. This group also exhibits more beneficial values of renal function parameters. Conclusion: Maintaining greater size of CD34 + and CD34 + VEGFR2 + populations as well as proper kidney function may constitute mechanisms that connect chemokine receptor polymorphism with cardiovascular system health.